But Playez you have been saying for years that tpm has no commercial value, that it doesn't work any better than what's already on the market, and that Mylan were not interested in it. It would appear you are wrong once again. You must be very embarrassed.
- Forums
- ASX - By Stock
- AVE
- European patent- improved daptomycin injectable
AVE
avecho biotechnology limited
Add to My Watchlist
11.1%
!
0.5¢

European patent- improved daptomycin injectable, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $15.86M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $17.08K | 3.426M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 24140598 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 12665942 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 24140598 | 0.004 |
30 | 19319932 | 0.003 |
15 | 12297700 | 0.002 |
15 | 55321222 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 12665942 | 16 |
0.006 | 4967199 | 7 |
0.007 | 4598187 | 13 |
0.008 | 3347500 | 4 |
0.009 | 2143333 | 4 |
Last trade - 15.58pm 29/07/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |